Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	12.37	78.35	69.72
Graham Fair Price	-1.17	25.63	25.93
PEG	-131.41	-7.49	-3.24
Price/Book	1.11	6.98	6.90
Price/Cash Flow	-47.82	281.37	539.21
Prices/Earnings	10.19	35.65	32.36
Price/Sales	5.75	23.06	21.81
Price/FCF	-47.82	281.37	539.21
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-5.16	0.39	0.41
Operating Margin	-4.52	0.21	0.22
ROA	-5.86	0.03	0.03
ROE	0.05	0.05	-8.25
ROIC	0.05	0.04	-8.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.22	-0.13	74.33
Dividends QOQ	< 0.005	0.06	18000.88
EBIT QOQ	-0.10	-0.06	44.22
EPS QOQ	-0.10	-0.05	52.38
FCF QOQ	-0.79	1.00	26.38
Revenue QOQ	-0.04	-0.01	70.88
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	21.79	< 0.005	-100.00
Days Sales Outstanding (DSO)	44.62	48.74	9.23
Inventory Turnover	4.13	328224000.00	7945687771.17
Debt/Capitalization	0.14	0.13	-5.97
Quick Ratio	1.12	0.85	-23.76
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	23.67	24.43	3.17
Cash	2.47	0.37	-84.87
Capex	-0.82	-0.73	10.20
Free Cash Flow	0.30	0.61	99.91
Revenue	7.49	7.39	-1.35
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.37	1.20	-12.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.31	1.76	33.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating